Roughly 25,000 Americans die each year from valvular heart disease, but researchers conclude that new technology could soon help doctors slash that number. The Lancet (2024) is a new generation of more flexible prostheses that the body will eventually replace with working organic valves, just as it constantly replaces existing tissue with new tissue.